ADA news: glycogen phosphorylase inhibitor displays hypoglycemic and cardioprotective effects June 15, 2000
Icos and Texas Biotechnology enter joint venture to develop and commercialize endothelin antagonists June 13, 2000
Combined AT1 blockade/ACE inhibition reduces blood pressure, protects kidney in CALM study June 6, 2000